Upstream Bio UPB
NASDAQ UPB
$3.20 -0.18 (-5.33%)
At close: Nov 11, 2026 · 4:00 PM EST

Upstream Bio (UPB) Price to Sales (2024 - 2026)

Updated

Upstream Bio's Price to Sales was 120.02 in Q2 2026, down 44.7% from 216.93 a year earlier and down 18.6% from the prior quarter.

Analysis

Upstream Bio (UPB) Price to Sales (2024 - 2026) Analysis & Trends

For FY2025, Price to Sales at Upstream Bio came in at 515.96, up 443.6% from FY2024.

  • In earlier years, Price to Sales was 94.91 in FY2024.
  • The Q2 2026 figure marks the lowest quarterly Price to Sales since Q4 2024.
  • Per Business Quant data, UPB's Price to Sales in the three quarters before Q2 2026 was 147.44 (Q1 2026), 515.96 (Q4 2025) and 362.89 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Upstream Bio 185.26 Mn -919.50 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 100.65
Jun 30, 2026 120.02
Mar 31, 2026 147.44
Dec 31, 2025 515.96
Sep 30, 2025 362.89
Jun 30, 2025 216.93
Mar 31, 2025 142.98
Dec 31, 2024 94.91
API Access

Upstream Bio Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=UPB&period=max&api_key=YOUR_API_KEY